Illinois And Copenhagen

EpiTherapeutics and Abbott Enter Into Oncology Collaboration on Epigenetic Targets

Older News

ABBOTT PARK, Illinois and COPENHAGEN, Denmark, December 20, 2010 - EpiTherapeutics and Abbott (NYSE: ABT) today announced a collaboration agreement to develop new anti-cancer drugs by making small-molecule inhibitors against selected epigenetic oncology targets.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy